Helius Therapeutics is a New Zealand-based biotechnology company, unleashing the extraordinary potential of cannabis to improve quality of life. The company has a bold vision: to create the most efficacious and safe cannabis medicines in the world.
Researchers at Helius are exploring the vast potential of cannabinoids in treating pain, sleep, anxiety and other chronic conditions. Future targets will extend beyond symptom relief into disease modification, particularly in the treatment of inflammatory and neurodegenerative conditions.
As the country’s largest, vertically-integrated medical cannabis business, Helius is developing state-of-the-art, GMP-certified facilities in Auckland encompassing a large-scale cultivation centre, an integrated extraction site, advanced cannabinoid research laboratories and pharmaceutical manufacturing operations.